TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Atlas Antibodies AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
161,752
|
148,126
|
142,457 |
Financial expenses |
24,793
|
9,677
|
4,511 |
Earnings before taxes |
51,314
|
77,825
|
56,272 |
EBITDA |
59,486
|
49,142
|
124,980 |
Total assets |
2,983,965
|
2,750,140
|
2,767,095 |
Current assets |
306,246
|
241,098
|
167,558 |
Current liabilities |
15,592
|
19,745
|
18,615 |
Equity capital |
2,449,098
|
2,249,052
|
2,257,490 |
- share capital |
495
|
463
|
477 |
Employees (average) |
70
|
82
|
79 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.1%
|
81.8%
|
81.6% |
Turnover per employee |
2,311
|
1,806
|
1,803 |
Profit as a percentage of turnover |
31.7%
|
52.5%
|
39.5% |
Return on assets (ROA) |
2.6%
|
3.2%
|
2.2% |
Current ratio |
1964.1%
|
1221.1%
|
900.1% |
Return on equity (ROE) |
2.1%
|
3.5%
|
2.5% |
Change turnover |
3,115
|
9,951
|
18,044 |
Change turnover % |
2%
|
7%
|
15% |
Chg. No. of employees |
-12
|
3
|
13 |
Chg. No. of employees % |
-15%
|
4%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.